Table 3.
Factors affecting mortality due to B. cereus in Pediatric Oncology Patients.
| Characteristic | Death (n = 9) | Recovery (n = 27) | P value | |
|---|---|---|---|---|
| Age | <5 year | 2/9 (22%) | 9/27 (33%) | 0.690 |
| >5 year | 7/9 (78%) | 18/27 (67%) | ||
| Gender | Male | 6/9 (67%) | 16/27 (60%) | 1.0 |
| Female | 3/9 (33%) | 11/27 (40%) | ||
| Disease | Acute leukemia | 9/9 (100%) | 19/27 (70%) | 0.160 |
| Others | 0 | 8/27 (30%) | ||
| GI symptoms | Present | 5/6 (83%) | 8/20 (40%) | 0.160 |
| Absent | 1/6 (17%) | 12/20 (60%) | ||
| CNS symptoms | Present | 6/8 (75%) | 7/18 (39%) | 0.202 |
| Absent | 2/8 (25%) | 11/18 (61%) | ||
| Local vs systemic | Localized | 1/9 (11%) | 10/16 (63%) | 0.033 |
| Systemic | 8/9 (89%) | 6/16 (37%) | ||
| Low ANC | Present | 8/9 (89%) | 16/18 (89%) | 1.0 |
| Absent | 1/9 (11%) | 2/18 (11%) | ||
| Use of steroid | Present | 5/5 (100%) | 6/11 (55%) | 0.119 |
| Absent | 0 | 5/11 (45%) | ||
| IT chemotherapy | Present | 4/5 (80%) | 5/17 (30%) | 0.116 |
| Absent | 1/5 (20%) | 12/17 (70%) | ||
| CVC | Present | 4/4 (100%) | 15/15 (100%) | 1.0 |
| Absent | 0 | 0 |